NCT03043924 2025-12-11
MRI-PCOS
University Hospital, Lille
Phase NA Completed
Clinical Trials
18 trialsNCT00984399 2025-12-09
Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT03271489 2025-07-22
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT05243823 2022-12-23
Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy
Novo Nordisk A/S
Completed
NCT03103087 2022-04-20
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT01923298 2022-02-10
Estradiol Levels in Patients Treated With Estring
University of Arizona
Phase 2 Completed
NCT02691494 2021-07-13
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
AbbVie
Phase 3 Completed
NCT01817530 2020-07-21
Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
AbbVie
Phase 2 Completed
NCT02654054 2020-06-29
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT02455453 2020-01-14
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
Washington University School of Medicine
Phase 2 Completed
NCT02273791 2018-10-29
HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients
Mansoura University
Completed
NCT01385280 2018-10-17
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
University of Arizona
Phase NA Completed
NCT02528383 2017-09-18
Trial of Vaginal Estrogen for Urogenital Symptom Relief in Women on Aromatase Inhibitors
UConn Health
Phase NA Completed
NCT02352597 2017-03-24
PCOS
Cairo University
Phase 4 Completed
NCT00586898 2016-03-25
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00324259 2015-02-16
Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer
Washington University School of Medicine
Phase 2 Completed
NCT00698035 2014-06-02
E-String
University of California, San Francisco
Phase 2 Completed
NCT00003771 2013-09-20
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed